NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 10 filers reported holding NLS PHARMACEUTICS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,747,126 | $6,321,839 | 0.18% |
| Affinity Asset Advisors, LLC | 400,000 | $440,000 | 0.15% |
| J. Goldman & Co LP | 204,329 | $224,762 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 37,096 | $40,806 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 3,406 | $3,747 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 14,362 | $15,798 | 0.00% |
| Tower Research Capital LLC (TRC) | 100 | $110 | 0.00% |
| Renaissance Technologies | 54,700 | $60 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 90 | $99 | 0.00% |